Detalhe da pesquisa
1.
Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
Kidney Int
; 93(2): 355-364, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061332
2.
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
Cells
; 13(2)2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247837
3.
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.
Haematologica
; 103(9): e424-e426, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703727
4.
Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform.
Mol Ther Nucleic Acids
; 34: 102038, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799328
5.
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell Therapy.
J Immunother
; 45(3): 150-161, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191428
6.
Overcoming Target Driven Fratricide for T Cell Therapy.
Front Immunol
; 9: 2940, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30619300
7.
Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition.
J Immunol Res
; 2016: 4215684, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27413760
8.
HLA monomers as a tool to monitor indirect allorecognition.
Transplantation
; 97(11): 1119-27, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24798312